The Recombinant Vaccines Market Growth  was valued at USD 9.18 billion in 2022. It is projected to reach USD 21.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2% during the forecast period from 2023 to 2030. Recombinant Vaccines have emerged as a significant player in the pharmaceutical industry, offering promising solutions for preventing and...